Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
As the main British base in Afghanistan, Camp Bastion, is handed over to Afghan troops we look back at Britain's role in the conflict.
The father of Ched Evans' rape victim claims people are trying to track down and kill his daughter over the ordeal.
Tacloban in the Philippines is still trying to pick up the pieces one year on from the devastating Typhoon Haiyan.